Form 4 for COSM Cosmos Health Inc.
Accepted 2023-07-24 00:00:00 ET · period of report 2023-07-20 · accession 0001477932-23-005492 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-24 | 2023-07-20 | COSM | Siokas Grigorios | CEO, Dir, 10% | P - Purchase | $2.48 | +181.5K | 1.33M | +16% | +$450.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2023-07-20 | P | A | 181,451 | $2.48 | 1,327,885 | D | — | — | (F1) Purchased under a Securities Purchase Agreement dated July 20, 2023. The offering was made pursuant to a Registered Direct Offering under Registration No. 333-267550. |